Waterhouse, R. N., Smith, M. F., Greer, K. L., Collier, T. L., Eberl, S., Towson, J., … Patz, E. F. (1998). Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent. JOURNAL OF NUCLEAR MEDICINE, 39(5), 227P-227P.

Waterhouse, R. N., M. F. Smith, K. L. Greer, T. L. Collier, S. Eberl, J. Towson, A. Birrell, et al. “Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent.” JOURNAL OF NUCLEAR MEDICINE 39, no. 5 (May 1, 1998): 227P-227P.

Waterhouse RN, Smith MF, Greer KL, Collier TL, Eberl S, Towson J, et al. Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent. JOURNAL OF NUCLEAR MEDICINE. 1998 May 1;39(5):227P-227P.

Waterhouse, R. N., et al. “Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent.” JOURNAL OF NUCLEAR MEDICINE, vol. 39, no. 5, SOC NUCLEAR MEDICINE INC, May 1998, pp. 227P-227P.

Waterhouse RN, Smith MF, Greer KL, Collier TL, Eberl S, Towson J, Birrell A, Gillin AG, Bautovich G, Jaszczak RJ, Patz EF. Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 1998 May 1;39(5):227P-227P.